Ernexa Therapeutics Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Ernexa Therapeutics Inc. (ERNA) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$1.62 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-15.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2016-03-15
- Ernexa Therapeutics Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2015-12-31 was -$331.00K.
- Ernexa Therapeutics Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2015-09-30 was -$477.00K.
- Ernexa Therapeutics Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2015-06-30 was -$378.00K.
- Ernexa Therapeutics Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2015-03-31 was -$437.00K.
- Ernexa Therapeutics Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$1.62M.
- Ernexa Therapeutics Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$1.90M.
- Ernexa Therapeutics Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$2.70M.
- Ernexa Therapeutics Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2012 was -$2.78M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month as first filed |
|---|---|---|---|---|---|---|
| 2015-12-31 | -$331.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | -$808.00K derived: sum of 2 quarters · filed 2016-03-15 | -$1.19M derived: sum of 3 quarters · filed 2016-03-15 | -$1.62M 10-K · filed 2016-03-15 | ||
| 2015-09-30 | -$477.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$855.00K derived: sum of 2 quarters · filed 2015-11-09 | -$1.29M 10-Q · filed 2015-11-09 | -$1.82M derived: sum of 4 quarters · filed 2016-03-15 | ||
| 2015-06-30 | -$378.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$815.00K 10-Q · filed 2015-08-10 | -$1.34M derived: sum of 3 quarters · filed 2016-03-15 | -$1.94M derived: sum of 4 quarters · filed 2016-03-15 | ||
| 2015-03-31 | -$437.00K 10-Q · filed 2015-05-08 | -$962.00K derived: sum of 2 quarters · filed 2016-03-15 | -$1.56M derived: sum of 3 quarters · filed 2016-03-15 | -$1.82M derived: sum of 4 quarters · filed 2016-03-15 | ||
| 2014-12-31 | -$525.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | -$1.12M derived: sum of 2 quarters · filed 2016-03-15 | -$1.38M derived: sum of 3 quarters · filed 2016-03-15 | -$1.90M 10-K · filed 2016-03-15 | ||
| 2014-09-30 | -$596.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$856.00K derived: sum of 2 quarters · filed 2015-11-09 | -$1.38M 10-Q · filed 2015-11-09 | -$2.43M derived: sum of 4 quarters · filed 2015-11-09 | ||
| 2014-06-30 | -$260.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$780.00K 10-Q · filed 2015-08-10 | -$1.83M derived: sum of 3 quarters · filed 2015-08-10 | -$2.43M derived: sum of 4 quarters · filed 2015-08-10 | ||
| 2014-03-31 | -$520.00K 10-Q · filed 2015-05-08 | -$770.00K 10-Q · filed 2014-05-15 | -$1.57M derived: sum of 2 quarters · filed 2015-05-08 | -$2.17M derived: sum of 3 quarters · filed 2015-05-08 | -$2.73M derived: sum of 4 quarters · filed 2015-05-08 | |
| 2013-12-31 | -$1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27 | -$1.65M derived: sum of 2 quarters · filed 2015-03-27 | -$2.21M derived: sum of 3 quarters · filed 2015-03-27 | -$2.70M 10-K · filed 2015-03-27 | -$2.45M 10-K · filed 2014-03-31 | |
| 2013-09-30 | -$602.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$1.16M derived: sum of 2 quarters · filed 2014-11-07 | -$1.65M 10-Q · filed 2014-11-07 | |||
| 2013-06-30 | -$560.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$1.04M 10-Q · filed 2014-08-14 | ||||
| 2013-03-31 | -$484.00K 10-Q · filed 2014-05-15 | |||||
| 2012-12-31 | -$2.78M 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |